A prospective, observational, comparative study on effects of newer P2Y12 receptor antagonists on inflammatory markers, in diabetic patients undergoing percutaneous coronary intervention - Nil

Dr Ankita Panigrahy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

研究概览

暂无简介。

•1.Patients aged between 35 - 70 years of either gender.
•2.Diabetic patients , with either stable angina, unstable angina or NSTEMI, with the above mentioned drug therapy and planned for PCI.
•3.Patients with Thrombolysis In Myocardial Infarction (TIMI) flow grade 3 after PCI.

•1.Patients posted for Coronary bypass surgery.
•2.Patients with uncontrolled diabetes
•3.History of stroke or transient ischemic attack or intracranial bleeding at any time
•4.Patients who had previous cardiac intervention
•5.Patients with cardiogenic shock or hypovolemia
•6.Left Ventricular Ejection Fraction (LVEF) < 30%
•7.Patients with ST segment elevated myocardial infarction
•8.Patients with chronic kidney disease stage 3 and beyond
•9.Patients requiring reintervention in the study period
•10.Need for chronic anti coagulation therapy
•11.Patients whose liver function test values are more than 2 times the upper limit of normal
•12.History of gastrointestinal bleeding within past 6 months
•13.Hypersensitivity to study drugs

发起方

Dr Ankita Panigrahy